These tests are not performed annually because it is known that, mainly in the case of pancreatic tumors, its diagnosis is based almost exclusively on biochemical screening by the detection of Chromogranin-A, since the abnormality of pancreatic hormones precedes the radiological detection of these tumors by at least five years [54]. This evidence concerns the gene CHGA and pancreatic neoplasm.